Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma - Wikidata - awgldk - TriplyDB

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

http://www.wikidata.org/entity/Q36793155

about

Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)Biomarkers in pancreatic adenocarcinoma: current perspectives Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis.Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer.Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer.Aberrant glycosylation as biomarker for cancer: focus on CD43.Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma Prognostic factors related with survival in patients with pancreatic adenocarcinoma Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures.Metastatic pancreatic adenocarcinoma presented as back pain in pregnancy: case report and review of literature.Primary analysis for clinical efficacy of immunotherapy in patients with pancreatic cancer.Implication of suspicious cytology in endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer.Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis.Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale".Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

P2860

Q26739910-87F87886-71C1-4A4A-8416-864FAB3CC158 Q26796523-D33246FA-E29A-42D0-96C5-CE1105697325 Q28072309-934A53C4-E507-4D48-BDB8-65A0C41F452C Q30235405-D061B8D5-1C43-440D-B4D9-BB1CCC68CB4A Q35138972-00B7C73B-B0A4-488E-838F-EC1E0E1BE332 Q36310097-B295ADD8-0A45-4560-BBBD-6662FD0EF531 Q36403838-2BCAD9FE-0843-411A-BB6D-8880330E421F Q37109728-08AA4387-5AAB-4024-BCD0-14CEC14654BA Q37259570-6BBB580D-3E43-4EE6-9D0C-30478D22B37F Q37327988-C5C2C866-C514-433B-BE48-819D80D3369A Q37367435-76443C32-60B8-42B8-89D7-435B960E45F0 Q37367504-750EA109-B392-406B-99A8-21CF5E4E3A53 Q37525286-B7823F2E-F24D-4552-AA77-FCAC603D4C89 Q37618865-03912E9B-E615-495D-A5C8-D028D5152F1D Q37717226-05FC3577-AEE3-452C-96A9-BEC52FA28148 Q38242807-E969B072-D1B9-497A-B076-EA41AD7CB274 Q38434946-DFF6BDE5-4266-4D20-838B-952AC8469F9E Q38525538-773A125F-1D0F-4D4D-982D-23C6B1F7E482 Q38632737-5DEC8DB5-5DF4-4780-960F-42573E09EF2D Q41598122-21F2F0EC-1DA2-43DA-9EB3-03933D99AA73 Q41908975-D06D9576-17ED-410C-BF4F-55ED2EA4421F Q43781103-43FED00F-5850-46D0-9C50-77BF2B083C96 Q50579768-103971A5-FCD1-4DFE-9890-097AC61D67CC Q58608661-EF575EF8-74D2-4326-8E24-C8A85CF9C430

P2860

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

http://www.wikidata.org/entity/Q36793155

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

@ast

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

@en

type

label

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

@ast

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

@en

prefLabel

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

@ast

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

@en

P1433

Q36793155-7F8BAD28-C114-4843-9227-9B6D25772B2A

P1476

Q36793155-4B5D6784-D553-4ED1-AD68-D8701AA23F45

P2093

Q36793155-0A1B3440-488A-4A6E-9EAF-F3B4F02157AA

Q36793155-64AB0E64-2AA5-407A-A578-891A7290FDAB

Q36793155-7F53FB07-6639-49C1-A9BA-CC0DEDE9657D

Q36793155-94A72E45-626B-40C6-A6F9-18E6A0940B3D

Q36793155-9E35CD85-2251-4EB7-9689-133C0D3BF84B

Q36793155-A1EAB9C7-0EC2-4DA1-A0FE-211094A1BADC

Q36793155-BB3071F3-5B44-43B6-8388-3F28650F1601

P2860

Q36793155-210EAE89-87DF-43C4-B35D-5F3B5CE58305

Q36793155-2BA3368E-CF94-4E37-B3C7-A65D4875EA19

Q36793155-2BB43BEA-BFE0-416D-8028-09B1D1521FC2

Q36793155-44782443-B52A-490E-9D8B-78E6C1EEDA46

Q36793155-47065DE1-9033-40FD-9BAA-32AEFE18D528

Q36793155-4E9CA2D0-589C-42C4-AFE0-B24A47908430

Q36793155-7AEEC1C7-59D7-4FAC-B47E-60C485DA9981

Q36793155-8407CCA0-1B61-47FC-86AB-C8CB5642BFAE

Q36793155-8FF5FF84-9E21-450C-A0D1-49CFCEC57CC2

Q36793155-A2F5E6D4-8E12-46D9-8B49-613930A22121

P304

Q36793155-7108E159-0D1E-4842-869D-5193A1E668DB

P31

Q36793155-C152B565-4D4C-40BE-B086-66C0334ACE49

P356

Q36793155-D740CA2C-AB8D-4151-9CB7-DE1FF8A3D7CA

P433

Q36793155-B5CDE940-8938-4D8C-AA51-67FB218F2B70

P478

Q36793155-47E0F0BD-E624-4144-A36A-2CC527FD3594

P577

Q36793155-15D41C29-21F8-4925-A983-134367CDC930

P5875

Q36793155-01E3F3C4-E64F-42EA-9D97-0DA4C1C7D057

P698

Q36793155-29022C5C-4E30-4B26-A25F-9B72E8D28367

P921

Q36793155-C537EE17-6114-46ED-814B-2CD55A4DFB74

P932

Q36793155-CFBC4F32-4537-4321-B1EE-0DBB58BA0D5C

P356

YMJ.2013.54.3.643

P1433

Yonsei Medical Journal

P1476

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

@en

P2093

Jae Bock Chung

http://www.w3.org/2001/XMLSchema#string

Jeong Youp Park

http://www.w3.org/2001/XMLSchema#string

Kyong Joo Lee

http://www.w3.org/2001/XMLSchema#string

Moon Jae Chung

http://www.w3.org/2001/XMLSchema#string

Seung Woo Park

http://www.w3.org/2001/XMLSchema#string

Seung Woo Yi

http://www.w3.org/2001/XMLSchema#string

Si Young Song

http://www.w3.org/2001/XMLSchema#string

P2860

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

Epidemiology of pancreatic cancer

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Specific antigen in serum of patients with colon carcinoma

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704

Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?

A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver.

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

P304

643-649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2013.54.3.643

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236100822

http://www.w3.org/2001/XMLSchema#string

P698

23549809

http://www.w3.org/2001/XMLSchema#string

P921

P932

3635646

http://www.w3.org/2001/XMLSchema#string